Agonist mediated conformational changes of solubilized calf forebrain muscarinic acetylcholine receptors

Abstract

Muscarinic receptors in calf forebrain membranes can be identified by the specific binding of the radiolabelled antagonist [ 3H]dexetimide. These receptors (2.8 pM/mg protein) comprise two non-interconvertible subpopulations respectively high and low agonist affinity but with the same antagonist affinity. For all the agonists tested the low affinity sites represent 85±5% of the total receptor population. 0.5% Digitonin solubilized extracts contain 0.8 pM muscarinic receptor/mg protein. In contrast with the membranes, these extracts contain only sites with low agonist affinity. The alkylating reagent N-ethylmaleimide causes an increase of the acetylcholine affinity for the low affinity sites in membranes as well as for the solubilized sites. This effect is time dependent until a maximal 3-fold increase in affinity is attained. The rate of N-ethylmaleimide action is enhanced by the concomitant presence of agonists. In contrast, N-ethylmaleimide does not affect antagonist binding. This suggests that agonists mediate a conformational change of both the membrane bound low affinity muscarinic sites and of the solubilized sites, resulting in their increased susceptibility towards NEM alkylation.